Skip to main content

Development phase

Articles  —  25 February Feb 2026

Mastering regulatory complexity: A Guide to derisking drug development in the US and Europe

Read More about Mastering regulatory complexity: A Guide to derisking drug development in the US and Europe
Videos  —  20 January Jan 2026

Cell and Gene Therapy Answers: What Sets Regenerative Cell Therapy Apart?

Read More about Cell and Gene Therapy Answers: What Sets Regenerative Cell Therapy Apart?
Articles  —  16 December Dec 2025

Accelerating complex drug metabolism testing with remarkable speed

Read More about Accelerating complex drug metabolism testing with remarkable speed
Articles  —  28 March Mar 2025

Rapid and robust preclinical development of CAR T-cell therapies

Read More about Rapid and robust preclinical development of CAR T-cell therapies
Articles  —  8 November Nov 2024

Cell and Gene Therapy Answers: Top considerations for ocular cell and gene therapies

Read More about Cell and Gene Therapy Answers: Top considerations for ocular cell and gene therapies
Articles  —  12 September Sep 2024

Why cell line screening is crucial for successul complement-dependent cytotoxicity (CDC) assay development

Read More about Why cell line screening is crucial for successul complement-dependent cytotoxicity (CDC) assay development
Articles  —  12 September Sep 2024

N-Glycan Characterization with LC-MS

Read More about N-Glycan Characterization with LC-MS
Articles  —  12 September Sep 2024

Centralized Analytical Laboratory White Paper

Read More about Centralized Analytical Laboratory White Paper
Articles  —  12 September Sep 2024

Labcorp Biopharmaceutical CMC Stability Services

Read More about Labcorp Biopharmaceutical CMC Stability Services
Articles  —  1 July Jul 2024

Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism

Read More about Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism
Articles  —  4 January Jan 2024

Preclinical oncology renovation

Read More about Preclinical oncology renovation
Articles  —  3 October Oct 2023

UK-REACH Planning

Read More about UK-REACH Planning
Articles  —  5 June Jun 2023

How to de-risk OECD 443 studies through optimized dose level selections

Read More about How to de-risk OECD 443 studies through optimized dose level selections
Articles  —  24 April Apr 2023

What does a central lab do? Four core services

Read More about What does a central lab do? Four core services
Articles  —  19 April Apr 2023

Alcohol-related liver disease: Inherent challenges and strategies for successful clinical trial conduct

Read More about Alcohol-related liver disease: Inherent challenges and strategies for successful clinical trial conduct
Articles  —  8 March Mar 2023

Program management services are now offered as part of Labcorp’s Preclinical Oncology Services

Read More about Program management services are now offered as part of Labcorp’s Preclinical Oncology Services
Articles  —  7 March Mar 2023

Enabling better access to kidney disease trials

Read More about Enabling better access to kidney disease trials
Articles  —  19 July Jul 2021

Estimate the Impact of Time Savings on Your Drug Development Program, Asset Value and Financial Company Performance

Read More about Estimate the Impact of Time Savings on Your Drug Development Program, Asset Value and Financial Company Performance
Articles  —  29 April Apr 2021

Are Payer Assessments Of Innovative Cancer Therapies Optimal Across Europe?

Read More about Are Payer Assessments Of Innovative Cancer Therapies Optimal Across Europe?